ENTITY
Pharmesis International

Pharmesis International (PHM SP)

8
Analysis
Health Care • Singapore
Pharmesis International Ltd. is an investment holding company specializing in the research, development, production, sale, and marketing of Western medicine and Traditional Chinese Medicine (TCM) formulated products. The company offers Western medicine under the Kinna brand and TCM products under the Longlife brand, primarily targeting liver and gall bladder illnesses. It was founded in 1996 and is headquartered in Singapore.
more
Exchange Announcement • 14 Aug 2026 19:03

Financial Statements and Related Announcement: Half Yearly Results

Exchange Announcement • 11 Aug 2026 17:38

Financial Statements and Related Announcement: Profit Guidance

Exchange Announcement • 13 Jul 2026 17:34

Mandatory Cash Dividend/ Distribution

Exchange Announcement • 25 May 2026 19:00

General Announcement: Minutes of Annual General Meeting held on 29 April 2026

Exchange Announcement • 30 Apr 2026 17:48

Annual Reports and Related Documents

x